Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Gehring, Adam J ^a   Koh, Sarene ^a,b   Chia, Adeline ^a   Paramasivam, Komathi ^a   Chew, Valerie Suk Peng ^c   Ho, Zi Zong ^a   Lee, Kang Hoe ^d   Maini, Mala K ^e   Madhavan, Krishnakumar ^f   Lim, Seng Gee ^f   Bertoletti, Antonio ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b KAROLINSKA INSTITUTE   (Sweden)

^c AGENCY FOR SCIENCE   (Singapore)

^d GLENEAGLES HOSPITAL   (Singapore)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CD161 ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 7; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NATURAL KILLER CELL RECEPTOR NKG2D; RANTES; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE; IL8 PROTEIN, HUMAN; PEPTIDE; VIRUS PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; HEPATITIS B; HUMAN; HUMAN CELL; MONONUCLEAR CELL; T LYMPHOCYTE; ACUTE DISEASE; CELL CULTURE; DRUG EFFECT; HEPATITIS B VIRUS; IMMUNOLOGY; LIVER; NEUTROPHIL; PATHOLOGY; SECRETION; SPECIES DIFFERENCE; VIROLOGY;

HEPATITIS B VIRUS;

ACUTE DISEASE; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOKINES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INTERLEUKIN-15; INTERLEUKIN-17; INTERLEUKIN-8; LIVER; NEUTROPHILS; PEPTIDES; SPECIES SPECIFICITY; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 80051875146     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023330     Document Type: Article

References (35)

1. Ganem D, Prince AM, (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350: 1118-1129.
2. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, et al. (2003) CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77: 68-76.
3. Asabe S, Wieland SF, Chattopadhyay PK, Roederer M, Engle RE, et al. (2009) The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection. J Virol 83: 9652-9662.
4. Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, et al. (1994) Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A 91: 3764-3768.
5. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, et al. (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825-829.
6. Tan AT, Loggi E, Boni C, Chia A, Gehring AJ, et al. (2008) Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol 82: 10986-10997.
7. Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, et al. (2007) Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 81: 4215-4225.
8. Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, et al. (1996) Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 98: 1185-1194.
9. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, et al. (1993) Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 178: 1541-1554.
10. Kakimi K, Lane TE, Wieland S, Asensio VC, Campbell IL, et al. (2001) Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med 194: 1755-1766.
11. Sitia G, Isogawa M, Kakimi K, Wieland SF, Chisari FV, et al. (2002) Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 99: 13717-13722.
12. Tan AT, Koh S, Goh W, Zhe HY, Gehring AJ, et al. (2010) A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J Hepatol 52: 330-339.
13. Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, et al. (2001) T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 107: 1433-1441.
14. Keller M, Spanou Z, Schaerli P, Britschgi M, Yawalkar N, et al. (2005) T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol 175: 7678-7686.
15. Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, et al. (2011) Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis. PLoS ONE 6: e21381.
16. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, et al. (2007) Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 204: 667-680.
17. Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, et al. (2003) Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 170: 4665-4672.
18. Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, et al. (2007) IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 117: 3498-3506.
19. Pene J, Chevalier S, Preisser L, Venereau E, Guilleux MH, et al. (2008) Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 180: 7423-7430.
20. Ji-Yuan Z, Zheng Z, Fang L, Zheng-Sheng Z, Ruo-Nan X, et al. (2010) Interleukin-17-producing CD4 T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51: 81-91.
21. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, et al. (2009) Late Developmental Plasticity in the T Helper 17 Lineage. Immunity 30: 92-107.
22. Curtis MM, Rowell E, Shafiani S, Negash A, Urdahl KB, et al. (2010) Fidelity of pathogen-specific CD4+ T cells to the Th1 lineage is controlled by exogenous cytokines, interferon-gamma expression, and pathogen lifestyle. Cell Host Microbe 8: 163-173.
23. Golden-Mason L, Kelly AM, Doherty DG, Traynor O, McEntee G, et al. (2004) Hepatic interleuklin 15 (IL-15) expression: implications for local NK/NKT cell homeostasis and development. Clin Exp Immunol 138: 94-101.
24. Zhang Z, Zhang S, Zou Z, Shi J, Zhao J, et al. (2011) Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 53: 73-85.
25. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, et al. (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 164: 2832-2838.
26. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A, (2003) IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 170: 2106-2112.
27. Badolato R, Ponzi AN, Millesimo M, Notarangelo LD, Musso T, (1997) Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood 90: 2804-2809.
28. Sawa Y, Arima Y, Ogura H, Kitabayashi C, Jiang JJ, et al. (2009) Hepatic interleukin-7 expression regulates T cell responses. Immunity 30: 447-457.
29. Schaerli P, Britschgi M, Keller M, Steiner UC, Steinmann LS, et al. (2004) Characterization of human T cells that regulate neutrophilic skin inflammation. J Immunol 173: 2151-2158.
30. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, et al. (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21: 357-366.
31. Ohteki T, Tada H, Ishida K, Sato T, Maki C, et al. (2006) Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo. J Exp Med 203: 2329-2338.
32. Suzuki A, McCall S, Choi SS, Sicklick JK, Huang J, et al. (2006) Interleukin-15 increases hepatic regenerative activity. J Hepatol 45: 410-418.
33. Kakumu S, Okumura A, Ishikawa T, Yano M, Enomoto A, et al. (1997) Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clin Exp Immunol 109: 458-463.
34. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, et al. (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26: 117-129.
35. Kim JV, Kang SS, Dustin ML, McGavern DB, (2009) Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457: 191-195.